StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.46+0.14 (+0.27%)

Close on Nov 19, 2026Market cap $7.15BP/E –Yield –

Cytokinetics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Cytokinetics's free cash flow for the twelve months ending Jun 30, 2026 was -$580.72M. For fiscal 2025 it was -$534.82M. The highest annual figure on record is $35.39M in fiscal 2016.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$534.82M–
FY2024Dec 31, 2024-$399.80M–
FY2023Dec 31, 2023-$415.75M–
FY2022Dec 31, 2022-$310.85M–
FY2021Dec 31, 2021-$191.39M–
FY2020Dec 31, 2020-$2.11M–
FY2019Dec 31, 2019-$93.53M–
FY2018Dec 31, 2018-$102.10M–
FY2017Dec 31, 2017-$104.64M-395.7%
FY2016Dec 31, 2016$35.39M+718.9%
FY2015Dec 31, 2015$4.32M–
FY2014Dec 31, 2014-$45.95M–
FY2013Dec 31, 2013-$8.26M–
FY2012Dec 31, 2012-$33.56M–
FY2011Dec 31, 2011-$46.04M–
FY2010Dec 31, 2010-$45.32M-676.2%
FY2009Dec 31, 2009$7.87M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$164.17M–
Q1 FY2026Mar 31, 2026-$151.39M–
Q4 FY2025Dec 31, 2025-$148.30M–
Q3 FY2025Sep 30, 2025-$116.86M–
Q2 FY2025Jun 30, 2025-$132.38M–
Q1 FY2025Mar 31, 2025-$137.28M–
Q4 FY2024Dec 31, 2024-$66.86M–
Q3 FY2024Sep 30, 2024-$102.20M–
Q2 FY2024Jun 30, 2024-$101.23M–
Q1 FY2024Mar 31, 2024-$129.51M–
Q4 FY2023Dec 31, 2023-$74.11M–
Q3 FY2023Sep 30, 2023-$96.43M–
Q2 FY2023Jun 30, 2023-$122.52M–
Q1 FY2023Mar 31, 2023-$122.69M–
Q4 FY2022Dec 31, 2022-$101.40M–
Q3 FY2022Sep 30, 2022-$90.37M–
Q2 FY2022Jun 30, 2022-$91.33M–
Q1 FY2022Mar 31, 2022-$27.75M–
Q4 FY2021Dec 31, 2021-$62.49M-237.1%
Q3 FY2021Sep 30, 2021-$54.47M-562.6%
Q2 FY2021Jun 30, 2021-$38.29M–
Q1 FY2021Mar 31, 2021-$36.15M–
Q4 FY2020Dec 31, 2020$45.60M–
Q3 FY2020Sep 30, 2020$11.78M–
Q2 FY2020Jun 30, 2020-$28.30M–
Q1 FY2020Mar 31, 2020-$31.18M–
Q4 FY2019Dec 31, 2019-$20.36M–
Q3 FY2019Sep 30, 2019-$21.27M–
Q2 FY2019Jun 30, 2019-$24.73M–
Q1 FY2019Mar 31, 2019-$27.16M–
Q4 FY2018Dec 31, 2018-$12.54M–
Q3 FY2018Sep 30, 2018-$32.59M–
Q2 FY2018Jun 30, 2018-$26.91M–
Q1 FY2018Mar 31, 2018-$30.07M–
Q4 FY2017Dec 31, 2017-$24.85M-132.3%
Q3 FY2017Sep 30, 2017-$25.93M–
Q2 FY2017Jun 30, 2017-$31.52M–
Q1 FY2017Mar 31, 2017-$22.33M–
Q4 FY2016Dec 31, 2016$76.98M–
Q3 FY2016Sep 30, 2016-$12.43M–

More Cytokinetics figures

See a number that looks wrong?